|
End-of-day quote
TEL AVIV STOCK EXCHANGE
2026-10-08
|
5-day change | 1st Jan Change | ||
| 1,676.00 ILa | +0.12% |
|
-6.32% | - |
| 07-14 | Rafa Laboratories Ltd. has completed an IPO in the amount of ILS 549.8718 million. | CI |
| 07-08 | Rafa Laboratories Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| RAFA | End-of-day quote | |
TEL AVIV STOCK EXCHANGE
| RAFA | Delayed |
| 1 day | +0.12% | ||
| 1 week | -6.32% | ||
| Current month | -7.45% | ||
| 1 month | -0.12% |
| 1 week | 1,577 |  | 1,789 |
| 1 month | 1,572 | | 1,999 |
| Current year | 1,401 | | 1,999 |
| 1 year | 1,401 | | 1,999 |
| 3 years | 1,401 | | 1,999 |
| 5 years | 1,401 | | 1,999 |
| 10 years | 1,401 | | 1,999 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ido Leshem
CEO | Chief Executive Officer | 50 | 2023-12-31 |
Gabi Hazan
COO | Chief Operating Officer | 58 | 2006-12-31 |
Yael Paula Tomer
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gillon Beck
BRD | Director/Board Member | 64 | 2020-12-30 |
Abraham Dadon
BRD | Director/Board Member | 70 | 2026-05-26 |
Amir Levin
BRD | Director/Board Member | 60 | 2007-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -6.32% | - | - | 534M | |
| -1.61% | +1.72% | +38.30% | +106.93% | 1,060B | |
| -0.76% | -0.84% | +35.21% | +62.70% | 623B | |
| +0.39% | +4.81% | +17.81% | +83.77% | 480B | |
| -0.29% | -0.99% | +64.79% | +37.06% | 352B | |
| -2.03% | +1.06% | +21.08% | +42.16% | 345B | |
| -1.92% | -0.29% | +10.54% | +33.20% | 274B | |
| -2.36% | -1.16% | -7.14% | +8.68% | 249B | |
| -1.37% | +0.04% | +38.29% | +52.33% | 223B | |
| +0.17% | -0.27% | +24.40% | +96.82% | 182B | |
| Average | -0.95% | -0.21% | +27.03% | +58.18% | 378.85B | |
| Weighted average by Cap. | -1.05% | +0.74% | +30.42% | +68.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 420M 0 137M 122M 114M 104M 195M 13.27B 197M 1.37B 536M 6.75B 515M 503M 21.69B | 418M 0 137M 122M 114M 103M 194M 13.22B 196M 1.37B 534M 6.72B 513M 501M 21.61B |
| Net income | 99.43M 0 32.44M 28.97M 27.03M 24.55M 46.2M 3.14B 46.65M 324M 127M 1.6B 122M 119M 5.13B | 100M 0 32.74M 29.23M 27.27M 24.77M 46.62M 3.17B 47.07M 327M 128M 1.61B 123M 120M 5.18B |
| Net Debt | - | - |
Employees
257
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-08 | ILA 1,676.00 | +0.12% | 15,240 |
| 26-10-07 | ILA 1,674.00 | 0.00% | 11,926 |
| 26-10-06 | ILA 1,674.00 | -5.05% | 15,982 |
| 26-10-05 | ILA 1,763.00 | -1.45% | 6,673 |
| 26-10-01 | ILA 1,789.00 | -1.21% | 14,000 |
- Stock Market
- Stocks
- RAFA Stock
Select your edition
All financial news and data tailored to specific country editions
